Colecchia, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.126
NA - Nord America 7.918
EU - Europa 3.746
SA - Sud America 2.568
AF - Africa 198
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 9
Totale 22.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.761
CN - Cina 2.332
SG - Singapore 2.101
BR - Brasile 2.083
HK - Hong Kong 1.873
GB - Regno Unito 880
VN - Vietnam 863
IT - Italia 830
SE - Svezia 526
RU - Federazione Russa 406
DE - Germania 256
BG - Bulgaria 204
AR - Argentina 203
ID - Indonesia 201
KR - Corea 175
FI - Finlandia 132
EC - Ecuador 114
IN - India 88
JP - Giappone 84
NL - Olanda 82
AU - Australia 78
MX - Messico 73
BD - Bangladesh 59
FR - Francia 58
TR - Turchia 58
UA - Ucraina 56
IE - Irlanda 50
ZA - Sudafrica 49
AT - Austria 44
CA - Canada 44
CO - Colombia 41
PY - Paraguay 38
IQ - Iraq 37
PL - Polonia 37
PK - Pakistan 36
EG - Egitto 34
RO - Romania 34
LT - Lituania 33
UZ - Uzbekistan 32
IR - Iran 30
ES - Italia 29
MA - Marocco 29
CL - Cile 27
VE - Venezuela 25
TN - Tunisia 22
KE - Kenya 19
PE - Perù 19
MY - Malesia 17
TH - Thailandia 15
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
MK - Macedonia 12
PH - Filippine 12
UY - Uruguay 12
BE - Belgio 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
NP - Nepal 10
SC - Seychelles 10
BH - Bahrain 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
DO - Repubblica Dominicana 8
GH - Ghana 7
KG - Kirghizistan 7
SA - Arabia Saudita 7
BO - Bolivia 6
CH - Svizzera 6
EU - Europa 6
GR - Grecia 6
JM - Giamaica 6
LB - Libano 6
PA - Panama 6
DZ - Algeria 5
HN - Honduras 5
NG - Nigeria 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
GE - Georgia 4
GT - Guatemala 4
PT - Portogallo 4
AM - Armenia 3
BW - Botswana 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
OM - Oman 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BY - Bielorussia 2
CG - Congo 2
GA - Gabon 2
LU - Lussemburgo 2
LV - Lettonia 2
Totale 22.614
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.878
Hong Kong 1.856
Singapore 1.229
Hefei 773
Fairfield 645
London 618
Ashburn 552
Nyköping 472
Beijing 340
Chandler 331
Ho Chi Minh City 326
Wilmington 259
São Paulo 244
Princeton 238
Woodbridge 231
San Diego 227
Houston 209
Los Angeles 204
Sofia 204
Cambridge 203
New York 197
Shanghai 173
Hanoi 172
Buffalo 169
Seoul 163
Seattle 160
The Dalles 132
Chicago 119
Jakarta 114
Milan 108
Helsinki 95
Modena 89
Moscow 87
Melbourne 68
Redondo Beach 67
Rio de Janeiro 67
Bologna 65
Dallas 65
Nuremberg 60
Southend 57
Ann Arbor 55
Rome 50
Porto Alegre 47
Tokyo 47
Belo Horizonte 45
Dublin 45
Salt Lake City 45
Kent 43
Munich 42
Haiphong 39
Da Nang 38
Quito 38
Bremen 37
Curitiba 36
Elk Grove Village 35
Guangzhou 35
Guayaquil 35
Jacksonville 35
Jersey City 35
Amsterdam 30
Tashkent 30
Kilburn 29
Brasília 28
Biên Hòa 27
Council Bluffs 27
Norwalk 27
Frankfurt am Main 26
Reggio Emilia 26
Warsaw 26
Campinas 23
Hải Dương 22
Tampa 22
Dearborn 21
Chennai 20
Johannesburg 20
Vienna 20
Lappeenranta 19
Buenos Aires 18
Mashhad 18
Nairobi 18
Orem 18
Salvador 18
Stockholm 18
Columbus 17
Phoenix 17
Manaus 16
Ribeirão Preto 16
Thái Bình 16
Asunción 15
Florence 15
Fortaleza 15
Goiânia 15
Ninh Bình 15
Parma 15
Santo André 15
Sorocaba 15
Bắc Ninh 14
Guarulhos 14
Lancaster 14
Montreal 14
Totale 14.857
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota and Celiac Disease. 266
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 229
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 225
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 212
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 211
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 208
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 195
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 172
Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease 171
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 166
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 165
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 164
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 161
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 159
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 159
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 156
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 154
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 149
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 147
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease 145
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 143
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 143
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma 137
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 136
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 136
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 134
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 134
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 132
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 132
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 132
Post COVID-19 irritable bowel syndrome 130
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 129
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 127
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 126
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT 125
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 124
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 124
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 124
Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition 124
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma 121
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load 121
The management of endoscopic retrograde cholangiopancreatography related infections risk: results of an italian survey at regional level 119
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 115
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 115
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 115
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 115
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 114
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 114
Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL) 112
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 112
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 112
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 111
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 111
Hepatic steatosis in obese patients: clinical aspects and prognostic significance 110
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 110
Gut microbiota and metabolic syndrome 109
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods 109
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 108
"Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?" 108
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 107
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 107
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 106
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 106
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 105
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 103
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 103
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance 102
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 102
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 101
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 101
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 100
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 100
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study 100
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 99
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 99
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 99
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 98
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study 97
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 97
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 97
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 97
Corrigendum to “Idiopathic pulmonary fibrosis and intestinal disorders: An observational study” [Ann Diagn Pathol 62 (2023) 152072] (Annals of Diagnostic Pathology (2023) 62, (S1092913422001745), (10.1016/j.anndiagpath.2022.152072)) 96
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 96
Gut microbiota and its pathophysiology in disease paradigms 96
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 95
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 95
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study 95
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 94
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 94
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation 93
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 93
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 92
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: A systematic review and meta-analysis 91
Diverticular disease of the colon: new perspectives in symptom development and treatment 91
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness. 91
Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning 90
Italian consensus conference for colonic diverticulosis and diverticular disease 89
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 89
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients 89
Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well) 88
Totale 12.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 21 16 28 76 27 60 12
2021/20222.566 35 27 12 8 34 29 743 185 338 48 754 353
2022/20231.813 307 184 151 85 162 208 46 249 211 30 87 93
2023/20242.351 30 91 133 139 469 157 129 220 364 140 130 349
2024/20257.601 141 33 55 540 1.415 1.030 683 358 1.029 447 611 1.259
2025/20267.860 956 761 1.916 2.725 1.323 179 0 0 0 0 0 0
Totale 22.965